- Report
- August 2023
- 112 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4505EUR$4,950USD£3,862GBP
- Report
- January 2024
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- November 2023
- 182 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- March 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- August 2022
- 82 Pages
Africa, Middle East
From €1365EUR$1,500USD£1,170GBP
- Report
- March 2024
- 44 Pages
Global
From €9096EUR$9,995USD£7,798GBP
- Clinical Trials
- October 2021
- 122 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- August 2022
United States
From €1766EUR$1,940USD£1,514GBP
- Report
- October 2024
- 71 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- March 2025
- 84 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Book
- May 2021
- 224 Pages
- Book
- November 2018
- 464 Pages
- Book
- September 2013
- 152 Pages

Retinitis is a condition that affects the retina, the light-sensitive tissue at the back of the eye. It is caused by a variety of factors, including genetic disorders, infections, and exposure to toxins. Symptoms of retinitis include blurred vision, difficulty seeing in dim light, and loss of peripheral vision. Treatment options include medications, laser therapy, and surgery.
Optical treatments for retinitis include corrective lenses, such as glasses and contact lenses, and low vision aids, such as magnifiers and telescopes. These treatments can help improve vision and reduce the risk of further vision loss.
The retinitis market is composed of companies that develop and manufacture products to treat retinitis. These products include medications, corrective lenses, and low vision aids. Companies in the retinitis market include Bausch + Lomb, Novartis, and Allergan. Show Less Read more